Skip to content

Retinalamin

Also called Retina polypeptide complex — a bovine retinal extract given by injection. NOT tretinoin

A polypeptide complex extracted from cattle retina and given by injection.

  • TypeBioregulator
  • FormInjectable
  • Researched forLongevity

Where to get Retinalamin

RUPharma
Injectable
Code CAMERON

Sold as the form named. Approved uses are on its label; the research here goes beyond them.

Shop injectable at RUPharma

The short version

  • Why people research itMitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
  • What the evidence isThe largest human literature of any product in the Khavinson organ-extract family, and all of it Russian: glaucomatous optic neuropathy (Makashova 2014), retinal abiotrophy (Khvatova 2005), and diabetic retinopathy monitored by optical coherence tomography (Malakhova 2024).
  • What to watchEye pain, redness or sudden loss of vision.

How Retinalamin works

A polypeptide complex extracted from cattle retina and given by injection — intramuscular, or beside the eye by the retrobulbar route. It is the injectable sibling of the eye cytamin, and it is the member of the Khavinson organ-extract family with the largest human literature, essentially all of it Russian and essentially all of it in glaucoma and diabetic retinopathy. The proposed mechanism is the class one: peptide fragments acting on retinal cell proliferation and differentiation. No composition has been published, so there is no named active substance to attach a mechanism to.

First, the correction, because a catalog tool got this wrong. Retinalamin is not tretinoin.

What it is, and where it sits in this family. But parenteral rather than oral, which puts it a rung above them on the delivery question and makes it the member of the family with the largest human literature.

  • Injectable

On the goal map: Brain & pineal (Organ-specific bioregulation)

Research on Retinalamin8 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Evidence on file: A registered medicine in Russia with a substantial Russian clinical literature. The one animal study of it that resolves in English found no neuroprotective effect.

Human clinical evidence

  • The largest human literature of any product in the Khavinson organ-extract family, and all of it Russian: glaucomatous optic neuropathy (Makashova 2014), retinal abiotrophy (Khvatova 2005), and diabetic retinopathy monitored by optical coherence tomography (Malakhova 2024).

  • The largest single study is about delivery, and its result is awkward: across 498 patients with open-angle glaucoma, intramuscular, retrobulbar and combined administration were comparable (Erichev 2020). If injecting behind the eye is no better than injecting into muscle, the effect being measured is not coming from local delivery.

  • Every one of those studies is unmasked, single-country and built on surrogate endpoints, without independent replication outside the region.

Correlative data

  • The negative result comes from the drug's own country. In 36 rabbits with photochemical retinal damage, no significant functional or morphological evidence of neuroprotection by Retinalamin was found (Suetov 2021).

  • At cell level the school reports inductive activity of retinal peptides (Khavinson 2002) and therapeutic sensitivity of retinal ganglion cells — the cells that die in glaucoma — to a targeted peptide bioregulator in culture (Avetisov 2019).

How the mechanism reads

  • It is not tretinoin. Tretinoin is all-trans retinoic acid with an FDA label; this is an undefined bovine retina polypeptide complex given by injection. An automated catalog match put the two together before a person looked.

    Mechanistic
  • No composition has been published — no sequence, no molecular weight distribution, no assay — so there is no named active substance for a mechanism to belong to.

    Mechanistic
  • It is the one product in this family whose route needs no defending: injecting removes the gut-wall objection that every cytamin tablet has to answer.

    Mechanistic

Sources

  • Suetov AA. Retinoprotective effects of Retinalamin studied in an experimental model of photochemical damage to rabbit retinas. Vestnik Oftalmologii 2021 [Russian] · PMID 34726859
  • Erichev VP, Lovpache DN, Yaremenko TV. [Peptide bioregulators: delivery and efficacy]. Vestnik Oftalmologii 2020 [Russian] · PMID 32366071
  • Makashova NV, Vasil'eva AE, Morozova NE, Ronzina IA. Application of Retinalamin for the treatment of glaucomatous optic neuropathy. Vestnik Oftalmologii 2014 [Russian] · PMID 25306728
  • Khavinson VKh. Inductive activity of retinal peptides. Bulletin of Experimental Biology and Medicine 2002 · PMID 12802458
  • Avetisov SE. Evaluation of therapeutic sensitivity of retinal ganglion cells to targeted peptide bioregulator in culture. Vestnik Oftalmologii 2019 [Russian] · PMID 30830079
  • Malakhova AI. Objective structural and functional monitoring of polypeptide retinal neuroprotective therapy in diabetic retinopathy. Vestnik Oftalmologii 2024 [Russian] · PMID 39569781
  • Khvatova AV, Khlebnikova OV, Meshkova GI, Tarasenkov AO, Shchuvatova EL, Stromova OV. Polypeptide bioregulators in the treatment of different-type abiotrophy of the retina. Vestnik Oftalmologii 2005 [Russian] · PMID 15881150

Retinalamin safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Bovine allergy: it is a cattle retina extract.
  • Active eye infection or inflammation, since the retrobulbar route puts a needle beside the eye.
  • Anticoagulant use: a retrobulbar injection can bleed behind the eye.
  • Using it instead of pressure control or laser for glaucoma or diabetic retinopathy: the one English-language animal study found no neuroprotection.
  • Pregnancy.

What’s expected

  • No clear effect predicted; the Russian literature is large but uncontrolled by Western standards.
  • Local ache at the injection site.
  • Mild fatigue.

Watch for

  • Eye pain, redness or sudden loss of vision.
  • A bulging eye or double vision after a retrobulbar approach.
  • Fever, hives or swelling.
  • Spreading redness around the site.

Labs that tell you it’s working

  • HbA1c (Hemoglobin A1c)
  • Lipid Panel
  • hs-CRP (C-Reactive Protein, High Sensitivity)
  • Vitamin A

Retinalamin is a bovine retinal polypeptide complex used in Russian glaucoma and diabetic retinopathy care; the retinopathy drivers are the checkable labs. PMID 25306728

Bloodwork to runHow you would know it is working: 7 tests in one order, code CAMERON

Retinalamin FAQ4 common questions

Is Retinalamin approved for human use?
Retinalamin is an approved medicine for the uses on its label. This page covers research beyond those uses, as education, not medical advice.
What is Retinalamin researched for?
Mitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
Which labs show whether it's doing anything?
HbA1c; Lipid Panel; hs-CRP; Vitamin A: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for Retinalamin: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what Retinalamin is. Skool covers how it is run.

Free on this page

What Retinalamin is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What Retinalamin is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The protocols: what to run together, in what order, for how long and when to stop
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy with codeJoin Skool